Global Preimplantation Genetics Diagnosis (PGD) Market Research Report 2025(Status and Outlook)
Description
Report Overview
Preimplantation Genetic Diagnosis (PGD) is a specialized genetic testing procedure used during in vitro fertilization (IVF) to identify genetic defects within embryos before they are implanted in the uterus. This process involves the removal of one or more cells from the embryo and analyzing them for specific genetic conditions, allowing parents to select embryos free of certain genetic disorders for implantation. PGD is primarily used by couples who are carriers of genetic diseases, have a family history of genetic disorders, or are of advanced maternal age. By enabling the selection of healthy embryos, PGD increases the chances of a successful pregnancy and reduces the risk of passing on genetic conditions to offspring.
The market for Preimplantation Genetic Diagnosis (PGD) is experiencing significant growth driven by several key factors. Firstly, advancements in genetic testing technologies have made PGD more accurate, reliable, and accessible, expanding its adoption among couples seeking to conceive. Secondly, the rising prevalence of genetic disorders and chromosomal abnormalities worldwide has increased the demand for PGD as a preventive measure to ensure healthy pregnancies. Additionally, the growing trend towards delayed parenthood in developed countries has led to an increase in the number of couples seeking fertility treatments, including IVF with PGD. Moreover, the expanding applications of PGD beyond genetic disease screening, such as gender selection and identifying chromosomally normal embryos, are further driving market growth.
In addition to technological advancements and increasing demand, the market for PGD is also influenced by regulatory factors, ethical considerations, and healthcare infrastructure. Regulatory frameworks governing the use of PGD vary across countries, impacting the availability and affordability of these services. Ethical debates surrounding the use of PGD for non-medical purposes, such as gender selection, can influence public perception and acceptance of these technologies. Furthermore, the accessibility of PGD services is influenced by the presence of specialized fertility clinics and trained professionals capable of performing these procedures. Overall, the market for PGD is poised for continued growth as advancements in genetic testing technology, increasing awareness of genetic disorders, and evolving regulatory landscapes shape the landscape of reproductive medicine.
This report provides a deep insight into the global Preimplantation Genetics Diagnosis (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Preimplantation Genetics Diagnosis (PGD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Preimplantation Genetics Diagnosis (PGD) market in any manner.
Global Preimplantation Genetics Diagnosis (PGD) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Natera
Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited
Market Segmentation (by Type)
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Preimplantation Genetics Diagnosis (PGD) Market
Overview of the regional outlook of the Preimplantation Genetics Diagnosis (PGD) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Preimplantation Genetics Diagnosis (PGD) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Preimplantation Genetic Diagnosis (PGD) is a specialized genetic testing procedure used during in vitro fertilization (IVF) to identify genetic defects within embryos before they are implanted in the uterus. This process involves the removal of one or more cells from the embryo and analyzing them for specific genetic conditions, allowing parents to select embryos free of certain genetic disorders for implantation. PGD is primarily used by couples who are carriers of genetic diseases, have a family history of genetic disorders, or are of advanced maternal age. By enabling the selection of healthy embryos, PGD increases the chances of a successful pregnancy and reduces the risk of passing on genetic conditions to offspring.
The market for Preimplantation Genetic Diagnosis (PGD) is experiencing significant growth driven by several key factors. Firstly, advancements in genetic testing technologies have made PGD more accurate, reliable, and accessible, expanding its adoption among couples seeking to conceive. Secondly, the rising prevalence of genetic disorders and chromosomal abnormalities worldwide has increased the demand for PGD as a preventive measure to ensure healthy pregnancies. Additionally, the growing trend towards delayed parenthood in developed countries has led to an increase in the number of couples seeking fertility treatments, including IVF with PGD. Moreover, the expanding applications of PGD beyond genetic disease screening, such as gender selection and identifying chromosomally normal embryos, are further driving market growth.
In addition to technological advancements and increasing demand, the market for PGD is also influenced by regulatory factors, ethical considerations, and healthcare infrastructure. Regulatory frameworks governing the use of PGD vary across countries, impacting the availability and affordability of these services. Ethical debates surrounding the use of PGD for non-medical purposes, such as gender selection, can influence public perception and acceptance of these technologies. Furthermore, the accessibility of PGD services is influenced by the presence of specialized fertility clinics and trained professionals capable of performing these procedures. Overall, the market for PGD is poised for continued growth as advancements in genetic testing technology, increasing awareness of genetic disorders, and evolving regulatory landscapes shape the landscape of reproductive medicine.
This report provides a deep insight into the global Preimplantation Genetics Diagnosis (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Preimplantation Genetics Diagnosis (PGD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Preimplantation Genetics Diagnosis (PGD) market in any manner.
Global Preimplantation Genetics Diagnosis (PGD) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Natera
Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited
Market Segmentation (by Type)
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Preimplantation Genetics Diagnosis (PGD) Market
Overview of the regional outlook of the Preimplantation Genetics Diagnosis (PGD) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Preimplantation Genetics Diagnosis (PGD) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
178 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Preimplantation Genetics Diagnosis (PGD)
- 1.2 Key Market Segments
- 1.2.1 Preimplantation Genetics Diagnosis (PGD) Segment by Type
- 1.2.2 Preimplantation Genetics Diagnosis (PGD) Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Preimplantation Genetics Diagnosis (PGD) Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Preimplantation Genetics Diagnosis (PGD) Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Preimplantation Genetics Diagnosis (PGD) Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Preimplantation Genetics Diagnosis (PGD) Product Life Cycle
- 3.3 Global Preimplantation Genetics Diagnosis (PGD) Sales by Manufacturers (2020-2025)
- 3.4 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Preimplantation Genetics Diagnosis (PGD) Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers Preimplantation Genetics Diagnosis (PGD) Sales Sites, Area Served, Product Type
- 3.8 Preimplantation Genetics Diagnosis (PGD) Market Competitive Situation and Trends
- 3.8.1 Preimplantation Genetics Diagnosis (PGD) Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Preimplantation Genetics Diagnosis (PGD) Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Preimplantation Genetics Diagnosis (PGD) Industry Chain Analysis
- 4.1 Preimplantation Genetics Diagnosis (PGD) Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Preimplantation Genetics Diagnosis (PGD) Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 PEST Analysis
- 5.6.1 Industry Policies Analysis
- 5.6.2 Economic Environment Analysis
- 5.6.3 Social Environment Analysis
- 5.6.4 Technological Environment Analysis
- 5.7 Global Preimplantation Genetics Diagnosis (PGD) Market Porter's Five Forces Analysis
- 5.7.1 Global Trade Frictions
- 5.7.2 Global Trade Frictions and Their Impacts to Preimplantation Genetics Diagnosis (PGD) Market
- 5.8 ESG Ratings of Leading Companies
- 6 Preimplantation Genetics Diagnosis (PGD) Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type (2020-2025)
- 6.3 Global Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
- 6.4 Global Preimplantation Genetics Diagnosis (PGD) Price by Type (2020-2025)
- 7 Preimplantation Genetics Diagnosis (PGD) Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Preimplantation Genetics Diagnosis (PGD) Market Sales by Application (2020-2025)
- 7.3 Global Preimplantation Genetics Diagnosis (PGD) Market Size (M USD) by Application (2020-2025)
- 7.4 Global Preimplantation Genetics Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
- 8 Preimplantation Genetics Diagnosis (PGD) Market Sales by Region
- 8.1 Global Preimplantation Genetics Diagnosis (PGD) Sales by Region
- 8.1.1 Global Preimplantation Genetics Diagnosis (PGD) Sales by Region
- 8.1.2 Global Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Region
- 8.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region
- 8.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region
- 8.2.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Preimplantation Genetics Diagnosis (PGD) Sales by Country
- 8.3.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Preimplantation Genetics Diagnosis (PGD) Sales by Country
- 8.4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Sales by Region
- 8.5.2 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Preimplantation Genetics Diagnosis (PGD) Sales by Country
- 8.6.2 South America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Sales by Region
- 8.7.2 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Preimplantation Genetics Diagnosis (PGD) Market Production by Region
- 9.1 Global Production of Preimplantation Genetics Diagnosis (PGD) by Region(2020-2025)
- 9.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region (2020-2025)
- 9.3 Global Preimplantation Genetics Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Preimplantation Genetics Diagnosis (PGD) Production
- 9.4.1 North America Preimplantation Genetics Diagnosis (PGD) Production Growth Rate (2020-2025)
- 9.4.2 North America Preimplantation Genetics Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Preimplantation Genetics Diagnosis (PGD) Production
- 9.5.1 Europe Preimplantation Genetics Diagnosis (PGD) Production Growth Rate (2020-2025)
- 9.5.2 Europe Preimplantation Genetics Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Preimplantation Genetics Diagnosis (PGD) Production (2020-2025)
- 9.6.1 Japan Preimplantation Genetics Diagnosis (PGD) Production Growth Rate (2020-2025)
- 9.6.2 Japan Preimplantation Genetics Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Preimplantation Genetics Diagnosis (PGD) Production (2020-2025)
- 9.7.1 China Preimplantation Genetics Diagnosis (PGD) Production Growth Rate (2020-2025)
- 9.7.2 China Preimplantation Genetics Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Basic Information
- 10.1.2 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.1.4 Abbott Laboratories Business Overview
- 10.1.5 Abbott Laboratories SWOT Analysis
- 10.1.6 Abbott Laboratories Recent Developments
- 10.2 Natera
- 10.2.1 Natera Basic Information
- 10.2.2 Natera Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.2.3 Natera Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.2.4 Natera Business Overview
- 10.2.5 Natera SWOT Analysis
- 10.2.6 Natera Recent Developments
- 10.3 Inc
- 10.3.1 Inc Basic Information
- 10.3.2 Inc Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.3.3 Inc Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.3.4 Inc Business Overview
- 10.3.5 Inc SWOT Analysis
- 10.3.6 Inc Recent Developments
- 10.4 PerkinElmer
- 10.4.1 PerkinElmer Basic Information
- 10.4.2 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.4.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.4.4 PerkinElmer Business Overview
- 10.4.5 PerkinElmer Recent Developments
- 10.5 Illumina
- 10.5.1 Illumina Basic Information
- 10.5.2 Illumina Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.5.3 Illumina Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.5.4 Illumina Business Overview
- 10.5.5 Illumina Recent Developments
- 10.6 F. Hoffmann-La Roche
- 10.6.1 F. Hoffmann-La Roche Basic Information
- 10.6.2 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.6.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.6.4 F. Hoffmann-La Roche Business Overview
- 10.6.5 F. Hoffmann-La Roche Recent Developments
- 10.7 Thermo Fisher Scientific
- 10.7.1 Thermo Fisher Scientific Basic Information
- 10.7.2 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.7.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.7.4 Thermo Fisher Scientific Business Overview
- 10.7.5 Thermo Fisher Scientific Recent Developments
- 10.8 Laboratory Corporation of America Holdings
- 10.8.1 Laboratory Corporation of America Holdings Basic Information
- 10.8.2 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.8.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.8.4 Laboratory Corporation of America Holdings Business Overview
- 10.8.5 Laboratory Corporation of America Holdings Recent Developments
- 10.9 Agilent Technologies
- 10.9.1 Agilent Technologies Basic Information
- 10.9.2 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.9.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.9.4 Agilent Technologies Business Overview
- 10.9.5 Agilent Technologies Recent Developments
- 10.10 Quest Diagnostics Incorporated
- 10.10.1 Quest Diagnostics Incorporated Basic Information
- 10.10.2 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.10.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.10.4 Quest Diagnostics Incorporated Business Overview
- 10.10.5 Quest Diagnostics Incorporated Recent Developments
- 10.11 Cooper Surgical
- 10.11.1 Cooper Surgical Basic Information
- 10.11.2 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.11.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.11.4 Cooper Surgical Business Overview
- 10.11.5 Cooper Surgical Recent Developments
- 10.12 Beijing Genomics Institute (BGI)
- 10.12.1 Beijing Genomics Institute (BGI) Basic Information
- 10.12.2 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.12.4 Beijing Genomics Institute (BGI) Business Overview
- 10.12.5 Beijing Genomics Institute (BGI) Recent Developments
- 10.13 Genea Limited
- 10.13.1 Genea Limited Basic Information
- 10.13.2 Genea Limited Preimplantation Genetics Diagnosis (PGD) Product Overview
- 10.13.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Product Market Performance
- 10.13.4 Genea Limited Business Overview
- 10.13.5 Genea Limited Recent Developments
- 11 Preimplantation Genetics Diagnosis (PGD) Market Forecast by Region
- 11.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast
- 11.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Country
- 11.2.3 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Region
- 11.2.4 South America Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Preimplantation Genetics Diagnosis (PGD) by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Preimplantation Genetics Diagnosis (PGD) by Type (2026-2033)
- 12.1.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Preimplantation Genetics Diagnosis (PGD) by Type (2026-2033)
- 12.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Application (2026-2033)
- 12.2.1 Global Preimplantation Genetics Diagnosis (PGD) Sales (K Units) Forecast by Application
- 12.2.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
